Jiang Zhong Pharmaceutical Co.,Ltd

SHSE:600750 Rapport sur les actions

Capitalisation boursière : CN¥13.2b

Jiang Zhong PharmaceuticalLtd Croissance future

Future contrôle des critères 2/6

Jiang Zhong PharmaceuticalLtd is forecast to grow earnings and revenue by 13.4% and 12.8% per annum respectively. EPS is expected to grow by 13.1% per annum. Return on equity is forecast to be 23.8% in 3 years.

Informations clés

13.4%

Taux de croissance des bénéfices

13.1%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices19.3%
Taux de croissance des recettes12.8%
Rendement futur des capitaux propres23.8%
Couverture par les analystes

Low

Dernière mise à jour29 Oct 2024

Mises à jour récentes de la croissance future

Recent updates

Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750) Analysts Just Slashed This Year's Revenue Estimates By 11%

Sep 12
Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750) Analysts Just Slashed This Year's Revenue Estimates By 11%

Lacklustre Performance Is Driving Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

Jul 20
Lacklustre Performance Is Driving Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

May 22
A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)

Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

Apr 15
Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E

Prévisions de croissance des bénéfices et des revenus

SHSE:600750 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20265,4351,003N/A1,2705
12/31/20254,844887N/A1,0675
12/31/20244,203766N/A4814
9/30/20244,125750701905N/A
6/30/20244,201747768971N/A
3/31/20244,2737338381,044N/A
12/31/20234,3907088271,036N/A
9/30/20234,2486868651,141N/A
6/30/20234,3466567701,084N/A
3/31/20234,2996577601,116N/A
12/31/20223,8855986761,022N/A
9/30/20223,811559595910N/A
6/30/20223,5095918291,101N/A
3/31/20223,127530608834N/A
12/31/20212,874506729917N/A
9/30/20212,644528326500N/A
6/30/20212,549510206357N/A
3/31/20212,594502507660N/A
12/31/20202,441474570753N/A
9/30/20202,481480597714N/A
6/30/20202,467482749858N/A
3/31/20202,437468627714N/A
12/31/20192,449464565641N/A
9/30/20192,167498661753N/A
6/30/20192,001494628739N/A
3/31/20191,832481354463N/A
12/31/20181,755470365486N/A
9/30/20181,731450280402N/A
6/30/20181,764436N/A313N/A
3/31/20181,778425N/A293N/A
12/31/20171,747418N/A173N/A
9/30/20171,764438N/A263N/A
6/30/20171,555386N/A396N/A
3/31/20171,497374N/A568N/A
12/31/20161,548372N/A698N/A
9/30/20161,805401N/A659N/A
6/30/20162,150424N/A619N/A
3/31/20162,455411N/A534N/A
12/31/20152,597367N/A511N/A
9/30/20152,664332N/A510N/A
6/30/20152,763308N/A512N/A
3/31/20152,757275N/A438N/A
12/31/20142,834265N/A357N/A
9/30/20142,952188N/A294N/A
6/30/20142,872154N/A245N/A
3/31/20142,829142N/A77N/A
12/31/20132,778172N/A112N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 600750's forecast earnings growth (13.4% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 600750's earnings (13.4% per year) are forecast to grow slower than the CN market (25.8% per year).

Croissance élevée des bénéfices: 600750's earnings are forecast to grow, but not significantly.

Chiffre d'affaires vs marché: 600750's revenue (12.8% per year) is forecast to grow slower than the CN market (14% per year).

Croissance élevée des revenus: 600750's revenue (12.8% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 600750's Return on Equity is forecast to be high in 3 years time (23.8%)

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y